Profiel
Noam Frey currently works at Summit Therapeutics, Inc., as Senior VP-Global Medical Affairs from 2023.
Dr. Frey also formerly worked at InterMune, Inc., as Vice President-Medical Affairs from 2013 to 2015 and Amryt Pharma Holdings Ltd., as Vice President-Medical Affairs from 2022 to 2023.
Dr. Frey received his Masters Business Admin degree from the University of Washington and doctorate degree from Tel-Aviv University.
Actieve functies van Noam Frey
| Bedrijven | Functie | Begin |
|---|---|---|
| SUMMIT THERAPEUTICS INC. | Corporate Officer/Principal | 01-09-2023 |
Eerdere bekende functies van Noam Frey
| Bedrijven | Functie | Einde |
|---|---|---|
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Hoofd Techniek/Wetenschap/O&O | 01-04-2023 |
| INTERMUNE INC | Hoofd Techniek/Wetenschap/O&O | 01-02-2015 |
Opleiding van Noam Frey
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Summit Therapeutics, Inc.
Summit Therapeutics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
















